UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

__________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~April 418, ~~2016~~2017

IMMUCOR, INC.

(Exact name of registrant as specified in its charter)

Georgia	~~Georgia~~0-14820	022-~~14820~~2408354	~~22-2408354~~
	(State or other jurisdiction	(Commission	(IRS Employer
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
	of incorporation)	File Number)	Identification No.)

3130 Gateway Drive, Norcross, Georgia	30071
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: (770) 441-2051

Not Applicable

(Former name or former address,

if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~Indicate 1by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.01405 ~~Entry~~of ~~into~~this achapter) ~~Material~~or ~~Definitive~~Rule ~~Agreement~~12b-2 of the Securities Exchange Act of 1934 (§240. 12b-2 of this chapter).

OnEmerging ~~May~~growth 4,company 2016, Immucor, Inc. (the “Company”), IVD Intermediate Holdings B Inc., the subsidiary guarantors party thereto, Citibank, N.A., as Administrative Agent, and the various revolving facility lenders party thereto modified the Company’s senior secured credit facilities by entering into Amendment No. 6 to the credit agreement among the parties dated as of August 19, 2011 (as previously amended, the “Credit Agreement”) (the “Amendment”).☐

~~The~~If ~~Amendment~~an ~~extends~~emerging ~~the~~growth ~~maturity~~company, ~~date~~indicate ~~under~~by ~~the~~check ~~existing~~mark ~~revolving~~if ~~credit~~the ~~facilities~~registrant ~~and~~has ~~amends~~elected ~~certain~~not ~~other~~to ~~terms~~use of the ~~revolving~~extended ~~credit~~transition ~~facilities. The~~period ~~margin~~ for ~~borrowings~~complying ~~under~~with ~~the~~any ~~revolving~~new ~~credit~~or ~~facility~~revised ~~remains~~financial ~~unchanged.~~accounting ~~With~~standards ~~respect~~provided topursuant ~~base rate borrowings, the margin is 2.75% and with respect~~ to ~~LIBOR~~Section ~~borrowings,~~13(a) ~~the~~of ~~margin is 3.75%. However,~~ the ~~Amendment~~Exchange ~~imposes a 0% LIBOR floor~~Act. ☐

~~The~~Item Amendment extends the maturity date of the revolving credit facilities to the earlier of (i) February 19, 2020, (ii) May 19, 2018, if the maturity of the term loan facility under the Credit Agreement have not been extended by such date, and (iii) 90 days prior to any maturity date of certain funded material indebtedness (which maturity date shall be no earlier than October 19, 2018)2. ~~Certain~~05 ~~other~~Costs ~~Company~~Associated ~~actions~~with ~~would~~Exit ~~also~~or ~~result~~Disposal ~~in a springing maturity of the revolving credit facilities as early as August 20, 2017~~Activities.

AsOn ~~amended~~April 18, 2017, Immucor, Inc. (the ~~aggregate~~“Company”) ~~principal~~committed ~~amount~~to ofa ~~the~~cost ~~revolving~~reduction ~~credit~~exercise. ~~commitments~~The isCompany ~~reduced~~has asinvested ~~follows:~~heavily ~~(1)~~across ~~effective~~all onfacets ~~May~~of 4,its ~~2016,~~business ~~from~~since ~~$100.0~~its ~~million~~acquisition toby ~~$80~~TPG Capital in August 2011.0 ~~million,~~These ~~(2)~~investments onhave ~~August~~included 19people, ~~2018~~systems, toprocesses ~~$70.0~~and ~~million~~acquisitions, ~~(3)~~resulted onin ~~February~~an ~~19,~~increase ~~2019,~~of tomore than $60.0 million ~~and~~in ~~(4)~~our oncost ~~August~~base ~~19,~~and ~~2019,~~added nearly 400 people to ~~$50.0~~the ~~million~~organization. The Company has undertaken a review of its cost structure and has taken steps to become more efficient and streamline our organization.

~~The~~As ~~revolving~~part ~~credit~~of ~~facilities~~this ~~also~~exercise, ~~provide~~the ~~that~~Company ifexpects ~~the~~to ~~existing~~generate ~~term~~approximately ~~loan~~$15 ~~facility~~million ~~under~~in ~~the~~annual ~~Credit~~cost ~~Agreement~~savings isbeginning ~~amended~~in fiscal year 2018, ~~then~~as ~~certain~~a ~~“most~~result ~~favored~~of ~~nations”~~reductions ~~provisions~~in ~~with~~both ~~respect~~headcount toand ~~interest~~discretionary ~~rate~~spending. ~~margin~~In ~~and~~connection ~~negative~~with ~~and~~this ~~financial~~cost ~~covenants~~reduction ~~will~~exercise, ~~apply~~the Company expects to incur approximately $3 million during the ~~revolving~~fourth ~~credit~~quarter ~~facilities.~~of fiscal year 2017 in one-time expenses, primarily for severance and other employee-related termination costs.

~~Except~~Forward-Looking ~~as modified by the Amendment, the remaining terms of the Credit Agreement remain in full force and effect.~~Statements

~~The~~Certain ~~foregoing~~statements ~~description~~herein, ofincluding the ~~Amendment~~expected benefits from the Company’s cost reduction exercise, are “forward-looking statements” based upon the Company’s current expectations and various assumptions. The Company believes there is ~~qualified~~a inreasonable basis for its ~~entirety~~expectations byand ~~reference~~beliefs, but any forward-looking statements are subject to ~~the~~various ~~full~~risks ~~text~~and ofuncertainties and there can be no assurance that the ~~Amendment,~~Company ~~which~~will isrealize ~~filed~~its asexpectations ~~Exhibit~~or 10that its beliefs will prove correct.1 Actual results of operations may differ materially from current expectations.

~~Item~~Important ~~2.03~~factors ~~Creation~~that ofcould acause ~~Direct~~the ~~Financial~~Company’s ~~Obligation~~actual orresults anto ~~Obligation~~differ ~~under~~materially anfrom ~~Off~~forward-~~Balance~~looking ~~Sheet~~statements ~~Arrangement~~are set forth in the section entitled “Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K and in all filings with the SEC made subsequent to the filing of the Form 10-K. The Company does not undertake to publicly update or revise any forward-looking statements, whether as a ~~Registrant~~result of new information, future events or otherwise.

~~The information set forth in Item 1.01 is incorporated by reference into this Item 2.03.~~SIGNATURES

~~Item~~Pursuant ~~9.01~~to ~~Financial~~the ~~Statements~~requirements ~~and~~of ~~Exhibits~~the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

10.1 Amendment No. 6 to the Credit Agreement.

	IMMUCOR, INC.


Date: April 19, 2017	By:	/s/ Dominique Petitgenet
		Dominique Petitgenet
		Vice President and Chief Financial Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	IMMUCOR, INC.
Date: May 10, 2016	By:	/s/ Dominique Petitgenet
		Dominique Petitgenet
		Vice President and Chief Financial Officer

Filing Compare · IMMUCOR INC